Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guerin therapy

被引:6
|
作者
Numakura, Satoe [1 ]
Morikawa, Teppei [1 ]
Ushiku, Tetsuo [1 ]
Toyoshima, Toyoaki [2 ]
Fukayama, Masashi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan
[2] Yuai Mem Hosp, Dept Urol, Koga, Japan
关键词
Eosinophilic granuloma; Histiocytosis X; Immunohistochemistry; Immunotherapy; Pathological diagnosis; ERDHEIM-CHESTER DISEASE; BRAF V600E MUTATION; EOSINOPHILIC CYSTITIS; MITOMYCIN-C; CARCINOMA; VEMURAFENIB; DIAGNOSIS; GRANULOMA; MELANOMA; TUMOR;
D O I
10.1016/j.prp.2013.11.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report an extremely rare case of Langerhans cell histiocytosis (LCH) of the urinary bladder. A 68-year-old man presented with gross hematuria. Cystoscopy showed multiple papillary tumors in the urinary bladder, and transurethral resection was performed. Pathological diagnosis was high-grade papillary urothelial carcinoma with lamina propria invasion. The patient received six treatments with intravesical Bacillus Calmette-Guerin (BCG) therapy. Seven months after surgery, follow-up cystoscopy showed three elevated lesions in the urinary bladder, two of which were identified histologically as recurrent urothelial carcinoma. Microscopic examination of the lesion at the anterior wall revealed diffuse infiltration of medium to large histiocytoid cells in the lamina propria, many of which had distorted nuclei and nuclear grooves. Dense eosinophilic infiltration was also observed. Immunohistochemically, the histiocytoid cells were diffusely positive for S-100 and CD1a, but negative for cytokeratin AE1/AE3 and melanosome-associated antigen recognized by HMB-45. Based on the histological and immunohistochemical features, we diagnosed the lesion as LCH of the urinary bladder. There was no evidence of recurrence of either bladder cancer or LCH after an 18-month follow-up. To avoid misdiagnosis, urologists and pathologists should be aware that LCH may develop in the urinary bladder after intravesical BCG therapy for bladder cancer. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 50 条
  • [1] Intravesical instillation therapy with bacillus Calmette-Guerin for superficial bladder cancer: Study of the mechanism of bacillus Calmette-Guerin immunotherapy
    Shintani, Yasuyo
    Sawada, Yoshihisa
    Inagaki, Takeshi
    Kohjimoto, Yasuo
    Uekado, Yasunari
    Shinka, Toshiaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (02) : 140 - 146
  • [2] Intravesical bacillus Calmette-Guerin for bladder cancer: are all the strains equal?
    D'Andrea, David
    Gontero, Paolo
    Shariat, Shahrokh F.
    Soria, Francesco
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 85 - 93
  • [3] Acute Arthritis Secondary to Intravesical Bacillus Calmette-Guerin for Bladder Cancer
    Raheem, O. A.
    Kalunian, K.
    Parsons, J. Kellogg
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (08): : 461 - 466
  • [4] Urinary interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin
    Thalmann, GN
    Sermier, A
    Rentsch, C
    Möhrle, K
    Cecchini, MG
    Studer, UE
    JOURNAL OF UROLOGY, 2000, 164 (06) : 2129 - 2133
  • [5] PROSPECTIVE RANDOMIZED COMPARISON OF INTRAVESICAL WITH PERCUTANEOUS BACILLUS CALMETTE-GUERIN VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN IN SUPERFICIAL BLADDER-CANCER
    LAMM, DL
    DEHAVEN, JI
    SHRIVER, J
    SAROSDY, MF
    JOURNAL OF UROLOGY, 1991, 145 (04) : 738 - 740
  • [6] The bacillus Calmette-Guerin as immunomodulator in bladder cancer
    Gabriel Vazquez-Lavista, Luis
    Haydee Flores-Balcazar, Christian
    Llorente, Luis
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2007, 59 (02): : 146 - 152
  • [7] Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-guerin association
    Kiehl, Isis G. A.
    Riccetto, Eduardo
    Salustiano, Ana C. C.
    Ossick, Marina, V
    Ferrari, Karen L.
    Assalin, Heloisa B.
    Ikari, Osamu
    Reis, Leonardo O.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (04) : 1187 - 1194
  • [8] Bacillus Calmette-Guerin (BCG) Therapy for Bladder Cancer: An Update
    Guallar-Garrido, Sandra
    Julian, Esther
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 1 - 11
  • [9] GRANULOMATOUS INFLAMMATION IN BLADDER WASH SPECIMENS AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    BETZ, SA
    SEE, WA
    COHEN, MB
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 99 (03) : 244 - 248
  • [10] Efficacy of intravesical Bacillus Calmette-Guerin therapy against tumor immune escape in an orthotopic model of bladder cancer
    Huang, Peng
    Ma, Chao
    Xu, Peng
    Guo, Kai
    Xu, Abai
    Liu, Chunxiao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (01) : 162 - 166